BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 23906602)

  • 1. Tools for probing and perturbing O-GlcNAc in cells and in vivo.
    Cecioni S; Vocadlo DJ
    Curr Opin Chem Biol; 2013 Oct; 17(5):719-28. PubMed ID: 23906602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics.
    Khidekel N; Ficarro SB; Clark PM; Bryan MC; Swaney DL; Rexach JE; Sun YE; Coon JJ; Peters EC; Hsieh-Wilson LC
    Nat Chem Biol; 2007 Jun; 3(6):339-48. PubMed ID: 17496889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
    Whelan SA; Hart GW
    Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global identification of O-GlcNAc-modified proteins.
    Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
    Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of O-GlcNAc modification of cellular proteins in signal transduction].
    Krześlak A
    Postepy Biochem; 2007; 53(4):389-99. PubMed ID: 19024903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc modification of Sp3 and Sp4 transcription factors negatively regulates their transcriptional activities.
    Ha C; Lim K
    Biochem Biophys Res Commun; 2015 Nov; 467(2):341-7. PubMed ID: 26431879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Interrogation to Crack the Case of O-GlcNAc.
    Estevez A; Zhu D; Blankenship C; Jiang J
    Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of transcription factor function by O-GlcNAc modification.
    Ozcan S; Andrali SS; Cantrell JE
    Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical approaches to understanding O-GlcNAc glycosylation in the brain.
    Rexach JE; Clark PM; Hsieh-Wilson LC
    Nat Chem Biol; 2008 Feb; 4(2):97-106. PubMed ID: 18202679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks.
    Slawson C; Housley MP; Hart GW
    J Cell Biochem; 2006 Jan; 97(1):71-83. PubMed ID: 16237703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation.
    Vocadlo DJ
    Curr Opin Chem Biol; 2012 Dec; 16(5-6):488-97. PubMed ID: 23146438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic nuclear and cytoplasmic glycosylation: enzymes of O-GlcNAc cycling.
    Iyer SP; Hart GW
    Biochemistry; 2003 Mar; 42(9):2493-9. PubMed ID: 12614143
    [No Abstract]   [Full Text] [Related]  

  • 13. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in chemical probing of protein
    Saha A; Bello D; Fernández-Tejada A
    Chem Soc Rev; 2021 Sep; 50(18):10451-10485. PubMed ID: 34338261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.
    Vosseller K; Wells L; Hart GW
    Biochimie; 2001 Jul; 83(7):575-81. PubMed ID: 11522385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
    Ogawa M; Sawaguchi S; Kamemura K; Okajima T
    Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAc signaling in cancer metabolism and epigenetics.
    Singh JP; Zhang K; Wu J; Yang X
    Cancer Lett; 2015 Jan; 356(2 Pt A):244-50. PubMed ID: 24769077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Reporters and Their Bioorthogonal Reactions for Labeling Protein
    Kim EJ
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30241321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The O-linked N-acetylglucosamine modification in cellular signalling and the immune system. 'Protein modifications: beyond the usual suspects' review series.
    Golks A; Guerini D
    EMBO Rep; 2008 Aug; 9(8):748-53. PubMed ID: 18617890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.